Jubilant Pharmova has a diversified & unique business model with new growth drivers & multiple triggers. It has growth visibility & revenue potential of $350 Mn. Co is embarking on a new earnings cycle. PAT has potential to grow 4x. TP ₹1450 (30%)
Jubilant Pharmova has a diversified & unique business model with new growth drivers. 30% upside
| Subscribe To Our Free Newsletter |
